These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


95 related items for PubMed ID: 7914102

  • 21. 5-fluorouracil and mast cell precursors in mice.
    Ophir A, Berenshtein E, Ziltener HJ, Razin E.
    Exp Hematol; 1993 Nov; 21(12):1558-62. PubMed ID: 8405236
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Interleukin 1 receptor antagonist inhibits normal hematopoiesis and reduces lethality and bone marrow toxicity of 5-fluouracil in mouse.
    Zhang J, Xiang D, Zhu S, Mao W, Lu H, Wu M, Wang Q, Yu Y, Herbst KD, Han W.
    Biomed Pharmacother; 2009 Aug; 63(7):501-8. PubMed ID: 18980827
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Erythropoiesis-stimulating properties of an antiserotonin drug under cytostatic treatment conditions].
    Skurikhin EG, Pershina OV, Ermakova NN, Andreeva TV, Khmelevskaia ES, Borsuk OS, Dygaĭ AM.
    Eksp Klin Farmakol; 2010 Mar; 73(3):21-4. PubMed ID: 20408425
    [Abstract] [Full Text] [Related]

  • 27. In vivo modulation of hematopoiesis by a novel hematoregulatory peptide.
    Pelus LM, King AG, Broxmeyer HE, DeMarsh PL, Petteway SR, Bhatnagar PK.
    Exp Hematol; 1994 Mar; 22(3):239-47. PubMed ID: 8112423
    [Abstract] [Full Text] [Related]

  • 28. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N, Chertkov J, Samoilina N, Zander A.
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Adrenergic dependence of hematopoietic precursors proliferation under cytostatic effect].
    Khlusov IA, Dygaí AM, Gol'dberg ED.
    Biull Eksp Biol Med; 1997 Jun; 123(6):638-41. PubMed ID: 9280514
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Adenosine A(3) receptor agonist acts as a homeostatic regulator of bone marrow hematopoiesis.
    Hofer M, Pospísil M, Znojil V, Holá J, Vacek A, Streitová D.
    Biomed Pharmacother; 2007 Jul; 61(6):356-9. PubMed ID: 17383145
    [Abstract] [Full Text] [Related]

  • 34. Experimental study of the bone marrow protective effect of a traditional Chinese compound preparation.
    Chen Y, Zhu B, Zhang L, Yan S, Li J.
    Phytother Res; 2009 Jun; 23(6):823-6. PubMed ID: 19173217
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dopaminergic regulation of granulocytopoiesis during cytostatic-induced myelosuppressions.
    Skurikhin EG, Minakova MY, Pershina OV, Dygai AM, Goldberg ED.
    Bull Exp Biol Med; 2007 Sep; 144(3):282-7. PubMed ID: 18457015
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In vivo and in vitro effects of 3-hydroxypyridin-4-one chelators on murine hemopoiesis.
    Hoyes KP, Jones HM, Abeysinghe RD, Hider RC, Porter JB.
    Exp Hematol; 1993 Jan; 21(1):86-92. PubMed ID: 8417963
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.